Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome

Christina Deligianni; Paolo Martelletti; Dimos D Mitsikostas

doi:10.57264/cer-2023-0082

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome

J Comp Eff Res. 2023 Jul;12(7):e230082. doi: 10.57264/cer-2023-0082. Epub 2023 Jun 2.

Authors

Christina Deligianni¹, Paolo Martelletti², Dimos D Mitsikostas³

Affiliations

¹ Department of Neurology, Athens Naval Hospital, Athens, Greece.
² Department of Clinical & Molecular Medicine, Sapienza University, Rome, Italy.
³ Department of Neurology, Aeginition Hospital, National & Kapodistrian University of Athens, Athens, Greece.

No abstract available

Keywords: Bayesian network meta-analysis; CGRP(r) monoclonal antibodies; eptinezumab; erenumab; fremanezumab; galcanezumab; migraine; network meta-regression; prevention; unanchored simulated treatment comparison.

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal
Humans
Migraine Disorders* / drug therapy

Substances

Antibodies, Monoclonal